3,000
Participants
Start Date
September 1, 2016
Primary Completion Date
December 1, 2016
Study Completion Date
December 1, 2016
Corticosteroid medication
Patients will be grouped into Cohort 1 (IR hydrocortisone), cohort 2 (IR prednisolone), cohort 3 (MR hydrocortisone), or cohort 4 (IR to MR hydrocortisone) depending on which oral corticosteroid medications were received during the observation period.
Lead Sponsor
Shire
INDUSTRY